A group of Israeli scientists say they’ll have a cure for cancer within a year.
The treatment is being cooked up by Accelerated Evolution Biotechnologies Ltd., a drug development company established in 2000, according to the Jerusalem Post.
“We believe we will offer in a year’s time a complete cure for cancer,” Dan Aridor, chairman of the board for AEBi, told the Post.
“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” Aridor added. “Our solution will be both generic and personal.”
The treatment is called MuTaTo, which stands for multi-target toxin, and is designed to act as a cancer antibiotic. MuTaTo uses several cancer-targeting peptides for each cancer cell at the same time, combined with a strong peptide toxin that would kill cancer cells, according to the Post.
“We made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer,” Dr. Ilan Morad, CEO of AEBi, said. “The probability of having multiple mutations that would modify all targeted receptors simultaneously decreases dramatically with the number of targets used.
“Instead of attacking receptors one at a time, we attack receptors three at a time — not even cancer can mutate three receptors at the same time,” Morad added.
AEBi is about to begin clinical trials that will wrap up in a few years. “Our results are consistent and repeatable,” Aridor said.